Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/32232
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dang, Yew Li | - |
dc.contributor.author | Yong, Vivien Ty | - |
dc.contributor.author | Sharmin, Sifat | - |
dc.contributor.author | Perucca, Piero | - |
dc.contributor.author | Kalincik, Tomas | - |
dc.date | 2023-02 | - |
dc.date.accessioned | 2023-03-01T03:56:06Z | - |
dc.date.available | 2023-03-01T03:56:06Z | - |
dc.date.issued | 2023-05 | - |
dc.identifier.citation | Multiple sclerosis (Houndmills, Basingstoke, England) 2023-05; 29(6) | en_US |
dc.identifier.issn | 1477-0970 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/32232 | - |
dc.description.abstract | Multiple sclerosis patients experience 3-6 times more seizures than the general population, but observations vary among studies. Seizure risk in disease-modifying therapy recipients remains unknown. | en_US |
dc.language.iso | eng | - |
dc.subject | Multiple sclerosis | en_US |
dc.subject | disease-modifying therapies | en_US |
dc.subject | epilepsy | en_US |
dc.subject | meta-analysis | en_US |
dc.subject | seizures | en_US |
dc.subject | systematic review | en_US |
dc.title | Seizure risk in multiple sclerosis patients treated with disease-modifying therapy: A systematic review and network meta-analysis. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | Multiple sclerosis | en_US |
dc.identifier.affiliation | Neurology | en_US |
dc.identifier.affiliation | Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia/Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand/Department of Neurology, Auckland City Hospital, Auckland, New Zealand. | en_US |
dc.identifier.affiliation | CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia. | en_US |
dc.identifier.affiliation | Neuroimmunology Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia/CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia. | en_US |
dc.identifier.doi | 10.1177/13524585231151400 | en_US |
dc.type.content | Text | en_US |
dc.identifier.orcid | 0000-0002-0570-5398 | en_US |
dc.identifier.orcid | 0000-0003-3778-1376 | en_US |
dc.identifier.pubmedid | 36802988 | - |
dc.description.startpage | 13524585231151400 | - |
local.name.researcher | Perucca, Piero | |
item.languageiso639-1 | en | - |
item.openairetype | Journal Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Neurology | - |
crisitem.author.dept | Comprehensive Epilepsy Program | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.